Sae‐Won Han

机构：Seoul National University Hospital · ORCID：0000-0003-3275-431X

发表论文 454 篇 · 总被引 11851 次 · h-index 59

代表论文

• Efficacy and safety of LY3537982, a potent and highly selective KRAS G12C inhibitor in KRAS G12C-mutant GI cancers: Results from a phase 1 study. (2024 · Journal of Clinical Oncology · 被引 32)
• Single-Agent Divarasib in Patients With KRAS G12C –Positive Non–Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study (2025 · Journal of Clinical Oncology · 被引 30)
• Immunogenomic characteristics and prognostic implications of terminally exhausted CD8+ T cells in colorectal cancers (2025 · Frontiers in Immunology · 被引 12)
• Amivantamab monotherapy in relapsed/refractory metastatic colorectal cancer: OrigAMI-1, an open-label, phase 1b/2 study. (2024 · Journal of Clinical Oncology · 被引 12)
• ARC-9: A randomized study to evaluate etrumadenant based treatment combinations in previously treated metastatic colorectal cancer (mCRC). (2024 · Journal of Clinical Oncology · 被引 10)
• Efficacy and safety of olomorasib, a second-generation KRAS G12C inhibitor, plus cetuximab in KRAS G12C-mutant advanced colorectal cancer. (2025 · Journal of Clinical Oncology · 被引 9)